• Mashup Score: 1

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Tweet Tweets with this article
    • Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

  • Mashup Score: 1

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Tweet Tweets with this article
    • Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

  • Mashup Score: 1

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Tweet Tweets with this article
    • Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

  • Mashup Score: 1

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Tweet Tweets with this article
    • Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/T0o8pRdEPB

  • Mashup Score: 0

    The urgent response to the COVID-19 pandemic has highlighted the importance of diverse, real-world data sources, such as electronic health records, insurance claims, and patient registries, to further inform evidence-based care amid an evolving public health crisis. Real-world data have the…

    Tweet Tweets with this article
    • Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYdfV #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role... https://t.co/ydLz0Girw8

  • Mashup Score: 1

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Tweet Tweets with this article
    • Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/DX1Qojj1q2

  • Mashup Score: 3

    This systematic review and meta-analysis assesses reports of clinical experiences of patients with COVID-19 and immunosuppression who were treated with specific neutralizing antibodies via COVID-19 convalescent plasma transfusion.

    Tweet Tweets with this article
    • COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [Jan 12, 2023] @jwsenefeld et al. @ACasadevall1 @DrMJoyner @JAMANetworkOpen https://t.co/MozmCs6oaS #COVID19CP #COVID19 https://t.co/AtCpeEMvLK